Silexion Therapeutics Corp (SLXN)
Develops RNA drugs delivered directly into tumors to treat cancer.
$2.45-0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-97.4%
The outlook
SLXN is trading near its 52-week low with a bearish sentiment score of 19/100. The stock sits below both its 50- and 200-day moving averages, reflecting weak near-term momentum. Notably, the average analyst price target sits significantly above the current price, though this wide gap reflects the stock's depressed valuation rather than near-term tailwinds.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +2349% vs current price
Market cap
$2.6M
52-wk high
$223.60
52-wk low
$2.20
50-day avg
$3.25
200-day avg
$15.92
Trailing P/E
—